USP
Articles
Rapid Sterility Tests for Short Shelf-Life Products: A Risk-Based Approach
May 9th 2018USP experts share current perspectives on a risk-based approach to rapid sterility tests for short shelf-life products such as cell and gene therapies. Live: Wednesday, May 9, 2018 at 12 pm EDT | 11 am CDT | 9 am PDT / On Demand available after airing until May 9, 2019. Register free: http://www.biopharminternational.com/bp_w/rapid
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: November 22nd 2024 | Updated: November 26th 2024
The Pharmacy Advantage in Direct-to-Patient Clinical Supply
Published: October 28th 2024 | Updated: November 26th 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 15th 2024 | Updated: November 26th 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 26th 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
